StonvexLoading…
StonvexStonvexStonvexCore line items from LRCX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-28 | Q1 2026 2026-03-29 | Q4 2025 2025-12-28 | Q3 2025 2025-09-28 | Annual 2025 2025-06-29 |
|---|---|---|---|---|---|
Revenue | $6.78B | $16.51B | $10.67B | $5.32B | $18.44B |
Operating Income | Not available | $5.69B | $3.64B | $1.83B | $5.90B |
Net Income | Not available | $4.99B | $3.16B | $1.57B | $5.36B |
EPS (Diluted) | $1.71 | $3.95 | $2.50 | $1.24 | $4.15 |
Total Assets | Not available | $20.79B | $21.39B | $21.90B | $21.35B |
Total Liabilities | Not available | $10.21B | $11.25B | $11.71B | $11.48B |
Cash & Equivalents | Not available | $4.75B | $6.18B | $6.69B | $6.39B |
Free Cash Flow OCF − CapEx | Not available | $3.62B | $2.81B | $1.59B | $5.41B |
Shares Outstanding | Not available | 1.25B | 1.25B | 1.26B | 1.27B |